A deal with AstraZeneca would help Pfizer add early-stage drugs in a field of cancer treatments that use the body’s own immune cells to recognize and attack tumors. AstraZeneca in January announced an agreement with Immunocore Ltd. to develop new treatments that use immune cells, and it also has several of its own immune-based drugs being tested in multiple cancers.
Nike Air Max 89 http://www.startlinescalemodels.co.uk/uk2014/airmaxau20142810s.asp?2810s=nike-air-max-89
